Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00292578 · ClinicalTrials.gov registry record · Phase 1
NAET® Testing Devices in Detection of Hypersensitivity to Cane Sugar
A Phase 1 study, sponsored by Nambudripad's Allergy Research Foundation.
- Completed
- Registry status
- Phase 1
- Development phase
- 75
- Enrollment target
NCT00292578: Completed Phase 1 study, sponsored by Nambudripad's Allergy Research Foundation.
NCT00292578 is a Phase 1 study that has completed, run by Nambudripad's Allergy Research Foundation. The registered enrollment target is 75 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (25% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00292578, a Phase 1 study, has completed, sponsored by Nambudripad's Allergy Research Foundation.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 75 participants
- Enrollment target
Study Summary
Background: Studies have noted a correlation between food sensitivities and health disorders. Various commonly seen health problems may be caused by cane sugar since it is lavishly and frequently used by people worldwide. Objective: This study evaluated the efficacy of NAET testing instruments in detecting hypersensitivities to cane sugar. Materials and Methods: Seventy-four subjects volunteered for this study. They were asked to write down one of their major health problems, the amount of sugar consumed on a daily basis and any known health problem(s) related to sugar consumption. The following testing modalities were used in the study: (1). Allergy Symptom-Rating Scale (ASRS); (2). NST Rating Scale (NSTRS); (3). Pulse Difference Rating Scale (PDRS). Test-1 was done twice. Tests 2 and 3 were done three times each: once without contacting sugar and then contacting sugar at one minute and ten minutes.
Interventions
- PROCEDURE NAET Testing Modalities
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2005-01 |
| Est. Completion | 2006-01 |
| Phase | Phase 1 |
What the finished NCT00292578 record still lists
NCT00292578 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (25% higher).
The record links to 0 conditions, and to 1 intervention - of which NAET Testing Modalities is the first listed.
NCT00292578 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00292578 about?
NCT00292578 is a clinical study titled "NAET® Testing Devices in Detection of Hypersensitivity to Cane Sugar". Background: Studies have noted a correlation between food sensitivities and health disorders. Various commonly seen health problems may be caused by cane sugar since it is lavishly and frequently used by people worldwide. Objective: This study evaluated the efficacy of NAET testing instruments in d...
What is the current status of trial NCT00292578?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 75 participants. The study started on 2005-01. Estimated completion is 2006-01.
What interventions are being tested in trial NCT00292578?
The interventions under investigation include: NAET Testing Modalities (PROCEDURE).
Who is sponsoring clinical trial NCT00292578?
This trial is sponsored by Nambudripad's Allergy Research Foundation, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00292578's enrollment target sits among peer trials
75 711th of 2000 higher than 1,276 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia